Without knowing more than you Andrew, I'm happy to consider that the Board has placed their focus on commercialising the IP.
Big guns are now focused on developing and supporting requirement for Pharma interest and preparing best-case offerings for new approaches.
Seeking to take a share of the Peptidream position as a starting point featuring competitive advantages could be a smart initiative.
Highly focused commercial executive, motivated support research, excites me more than highly qualified Professors exploring prospective breakthroughs at this time. GLTA
PYC Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)